Team:UQ-Australia/Project

From 2011.igem.org

(Difference between revisions)
(→Modelling)
 
(33 intermediate revisions not shown)
Line 1: Line 1:
-
{| style="color:#7B68EE;background:#E6E6FA" cellpadding="5" cellspacing="2" border="2" bordercolor="#4B0082" width="100%" align="center"
+
{{:Team:UQ-Australia/Template:Header}}
-
!align="center"|[[Team:UQ-Australia|Home]]
+
{|style="width:100%;" border="0" cellpadding="10" cellspacing="0"  
-
!align="center"|[[Team:UQ-Australia/Team|Team]]
+
|- valign="top"
-
!align="center"|[https://igem.org/Team.cgi?year=2011&team_name=UQ-Australia Official Team Profile]
+
|rowspan="2"|The human circadian rhythm drives many important processes in the body in accordance with the sleep/wake cycle. A characteristic of this biological clock is the periodic oscillation of gene expression. Current parts in the Registry designed to regulate periodic oscillations of gene expression have shown limited success.
-
!align="center"|[[Team:UQ-Australia/Project|Project]]
+
Here we demonstrate the feasibility of a biological clock being standardised as a set of BioBrick parts.
-
!align="center"|[[Team:UQ-Australia/Parts|Parts Submitted to the Registry]]
+
-
!align="center"|[[Team:UQ-Australia/Modeling|Modelling]]
+
-
!align="center"|[[Team:UQ-Australia/Notebook|Notebook]]
+
-
!align="center"|[[Team:UQ-Australia/Safety|Safety]]
+
-
!align="center"|[[Team:UQ-Australia/Attributions|Attributions]]
+
-
|}
+
-
{|align="justify"
+
-
|You can write a background of your team here. Give us a background of your team, the members, etc. Or tell us more about something of your choosing.
+
-
|[[Image:UQ-Australia_logo.png|200px|right|frame]]
+
-
|-
+
-
|
+
-
''Tell us more about your project.  Give us background.  Use this is the abstract of your project. Be descriptive but concise (1-2 paragraphs)
+
-
<span style="color:#8A2BE2"> We can assure that our project will be on time. </span>''
+
Our network is controlled by an engineered promoter, Plac/ara, which features both an activator and a repressor domain. This controls the production of downstream genes to activate other inducible promoters, pBAD and GlnAp2, eventually leading to the production of a repressor protein, lacI, which inhibits Plac/ara, resulting in oscillatory expression. This project shows the feasibility of standardising the biological clock in E. coli and grounds further development for applications in regulated drug/hormone delivery and ion channel control.
-
|[[Image:UQ-Australia_team.png|right|frame|Your team picture]]
+
! [[File:UQ-Australia_logo_2011.png|125x125px|link=https://2011.igem.org/Team:UQ-Australia]]
|-
|-
|
|
-
|align="center"|[[Team:UQ-Australia | Team Example]]
 
|}
|}
-
<!--- The Mission, Experiments --->
 
 +
== <span style="color:#558822">Project Details==
 +
The project has been split into categories:
 +
* Development of BioBricks
 +
** Experimental methods to be fully recorded in the [[Team:UQ-Australia/Notebook|Notebook]]
 +
* Modelling of the circuit
 +
** Modelling of the kinetics of the oscillating cells
 +
** Modelling of the synchronisation of oscillating cells
 +
* Thorough evaluation of the safety issues regarding UQ-Autralia's entry in iGEM
 +
* Human practices
 +
** Raising awareness of synthetic biology
 +
** Providing a solution to the patenting issue that iGEM is facing
 +
Together, this forms the UQ-Australia project for the 2011 iGEM.
 +
=== <span style="color:#D4A017">Motivation and Background</span> ===
-
== '''Overall project''' ==
+
In humans, the circadian rhythm is controlled by several core genes that operate via a series of feedback loops (Figure 1). A transcription–translation negative-feedback loop powers the system, with a delay between the transcription of these genes and the negative feedback being a key factor that allows the system to oscillate [1]. A 'master clock' located in the Suprachiasmatic Nucleus coordinates the timing of the rhythm, but external factors such as light exposure play a large role in regulating the exact
 +
<b>Figure 1: The gene network responsible for establishing the circadian rhythm in humans [1]</b>
-
Inspired by the circadian clock in humans which regulates a number of very important processes, we are trying to replicate this biological clock in a bacterial system. We are aiming to construct a network of genes that oscillates in a similar fashion to the 24 hour system in humans. If we are successful, we will be able to put different genes into our system so that we can make the bacteria perform a particular process periodically – a simple example of this would be to make them flash on and off consistently.
+
[[File:Mammalian.png]]
-
To achieve this oscillatory behaviour we will utilise a gene network with a series of inducible promoters that generate the production of other activating proteins, all driven by a constitutively active promoter. This promoter features an engineered repression domain (the inhibitor of this promoter being the output of the final step in the network). If everything goes as planned, these linked activations and repression will produce fluctuating levels of the proteins in question, which could then be used to drive our output function (initially just GFP production and a timed fluorescence). Ultimately, we hope our system could be used to drive the timed release of drugs or other biological factors.
+
There has been much effort put into reconstructing and determining the exact nature of this system, as the impact the circadian rhythm has on our lifestyle and cellular processes are still not very well understood. In particular, it is believed the circadian rhythm could exert an effect on everything from body temperature, feeding behaviour and appetite, hormone secretion and metabolism, glucose homeostasis, and cell-cycle progression [2].  
-
== Project Details==
+
Consequently, there have been a number of efforts to reconstruct this clock in a mammalian system for further study. In particular, both Hong <i>et al</i>. [3] and Tigges <i>et al</i>. [4] utilize the inducible tTa system to drive the expression and oscillation of genes in their synthetic networks.
-
The project has been split into categories:
+
It was our initial plan to construct a similar oscillatory system ourselves using standardized parts which could be added to the registry and then utilized by other iGEM teams working in mammalian cells. Such as system could be 'plugged in' to any number of different outputs and would allow for the timely and regular expression of the genes it drives. However, we encountered a number of issues around the intellectual property protecting of certain elements we wanted to use and so decided to switch to a simpler system in <i>E. coli</i>.
-
* Development of BioBricks
+
-
** Experimental methods to be fully recorded in the [[Team:UQ-Australia/Notebook|Notebook]]
+
-
* Modelling of the circuit
+
-
** Modelling of the kinetics of the oscillating cells
+
-
** Modelling of the synchronisation of oscillating cells
+
-
* Thorough evaluation of the safety issues regarding UQ-Autralia's entry in iGEM
+
-
* Human practices
+
-
** Raising awareness of synthetic biology
+
-
** Providing a solution to the patenting issue that iGEM is facing
+
-
Together, this forms the UQ-Australia project for the 2011 iGEM.
+
=== <span style="color:#D4A017">Our System</span> ===
 +
In prokaryotic systems, there are a number of tools available for synthetic biologists to construct gene networks such as the circadian clock we hope to replicate. In particular, we are going to make use of the inducible promoters glnAp2 and pBAD and their inducers glnG and araC. These components have been used in synthetic oscillators from both Atkinson <i>et al</i>. [5] and Stricker <i>et al</i>. [6]. In addition, we plan on using an engineered promoter denoted as Plac/ara, which features a pBAD activation domain as well as several lacO sites, meaning it is both inducible and repressible depending on the input. This promoter was first engineered by Lutz & Bujard [7].
 +
Based on the work from these previous studies, we designed our own system using components that have been previously utilized to construct other synthetic clocks (Figure 2). We decided to make a 3 component system rather that a dual component system as the issues encountered by some other synthetic clocks suggest that there might not have been enough time between the transcription of various components [8]. As such, including this extra step to add a delay should ensure our network is able to reach an oscillatory expression pattern.
 +
<b>Figure 2: The genetic system we are aiming to construct in order to produce an oscillating gene network. An engineered promoter, Plac/ara, which features both an activator and a repressor domain controls the production of downstream genes to activate other inducible promoters, pBAD and GlnAp2. These eventually lead to the production of a repressor protein, lacI, which inhibits Plac/ara, resulting in oscillatory expression.</b>
-
=== Experimental Work ===
+
[[File:Oursystem.png]]
 +
Once our system has been constructed, we hope to be able to make it even more stable by integrating the necessary components into the <i>E coli</i> chromosome. In this manner, we will be able to remove any interfering factors from our system, and will also be able to control the gene dosage level of our system. This has been a particular problem for other synthetic oscillators, with researchers being unable to control for the uptake of plasmid and therefore having cell-to-cell differences in the rate of oscillation [4, 6].
 +
Kuhlman & Cox [9] have developed a method for integrating large synthetic constructs into the bacterial chromosome, and kindly provided us with the necessary plasmids should we reach this stage. Furthermore, Dr. Alex Ninfa [5] provided us with <i>E. coli</i> strain 3.300L*G, which has both glnG and lacI knocked out so as not to interfere with the network we construct.
-
At the completion of the experimental work, we should expect a working clock BioBrick, which should exhibit oscillatory behaviour. We wish to characterise how our clock BioBrick oscillates.
 
-
Of interest is the frequency and regularity at which it oscillates and whether multiple cells containing our BioBrick oscillate in time with each other.
 
-
The modelling will involve the mathematical characterisation of the kinetics and synchronisation of the oscillation of our bacteria.
+
Details on the modelling behind out circuit can be found on the [[Team:UQ-Australia/Modeling|Modelling]] page.
-
The kinetics involve modelling how fast our bacteria cells will oscillate and the shape of their oscillation pattern.
+
-
The synchronisation is to characterise how quickly nearby cells would couple any synchronise their oscillation.
+
-
To give a rough idea of how our cells should be oscillating, mathematical models were described from literature. These would ideally be compared with experimental characterisation of the oscillation.
+
=== <span style="color:#D4A017">Experimental Outline & Goals</span> ===
-
=== Safety ===
+
Our main aim for the experimental work is to produce each component as a standardized and characterised BioBrick part that can be re-used by other teams in future to build their own oscillators. In the long run, we would hope to produce an <i>E. Coli</i> strain incorporating the three main 'modules' of our oscillator. In this manner, other teams could use this strain and simply transform the bacteria with a plasmid driven by one of our inducible promoters in order to obtain regular, oscillating expression.
-
Details of this is on the [[Team:UQ-Australia/Safety|Safety]] page.
+
To achieve these goals, we must first source all the components we require and standardize them to include BioBrick sites. Standard BioBrick assembly can then be used to construct our main components, before we will utilize a pre-determined system and protocols [9] to attempt to integrate our modules into the chromosome. In the process of developing our parts and constructing the system, we hope to characterise all our parts. In particular, confirming the inducibility and kinetics of our promoters will allow us to refine our models.  
 +
=== <span style="color:#D4A017">Other activities</span> ===
-
=== Human Practices ===
+
Our safety analysis is on the [[Team:UQ-Australia/Safety|Safety]] page, while the Human Practices discussion is in the [[Team:UQ-Australia/Human_Practices|Human Practices]] section.
-
==== Outreach ====
 
 +
=== <span style="color:#D4A017">References</span>===
-
==== Patenting ====
+
[1] Gallego, M & Virshup, DM 2007. "Post-translational modifications regulate the ticking of the circadian clock", <i>Molecular Cell Biology</i>, vol. 8, pp. 139-148.
-
In a dynamic field such as synthetic biology, discovery moves at an astounding pace and is driven by the findings of groups from all around the world. However, conflict often arises when the choice between collaboration and commercialisation arises, and consequently patents have become commonplace in the scientific world. In the last 5 years, 34% of respondents had applied for or received a patent on their findings. Additionally, 68% stated that they had sent research tools to others in academia [1]. This is especially relevant in iGEM, a competition whose explicit aim is to remain open source and collaborative. We examine whether this is a realistic or achievable goal within the framework of patents in the scientific world.  
+
[2] Takahashi, JS, Hong, HK, Ko, CH & McDearmon, EL 2008. "The genetics of mammalian circadian order and disorder: implications for physiology and disease", <i>Genetics</i>, vol. 9, pp. 764-775.
 +
[3] Hong, HK, Chong, JL, Song, W, Song, EJ & Jyawook, AA <i>et al</i>. 2007. "Inducible and reversible <i>Clock</i> gene expression in brain using the tTa system for the study of circadian behaviour", <i>PLoS Genetics</i>, vol. 3, no. 2, 324-338.
-
Within iGEM, the stipulation that all BioBricks must remain open source and redistributable means that patented material is inherently excluded from submission. This sort of restriction differs somewhat from the usual research experience, where 91% of scientists have not checked for patents on the material they used in the last 5 years [1]. However, iGEM falls in a unique `grey area’, which effectively prevents the use of any patented materials by participating teams with the requirement to submit their parts to the Registry to be redistributed. Although teams are using parts solely for research purposes, the nature of the registry and iGEM’s distribution kits means that by redistributing parts iGEM would be infringing on the patent holder. The UQ-Australia iGEM team has had to remodel their circuit design after encountering patents on key components.
+
[4] Tigges, M, Marques-Lago, TT, Stelling, J & Fusseneger, M 2009. "A tunable synthetic mammalian oscillator", <i>Nature</i>, vol. 457, pp. 309-312.
 +
[5] Atkinson, MR, Savageau, MA, Myers, JT & Ninfa, AJ 2003. "Development of genetic circuitry exhibiting toggle switch or oscillatory behaviour in Escherichia coli", <i>Cell</i>, vol. 113, pp. 597-607.
-
In the past, the issue of patenting has been less significant on iGEM with a recent survey indicating that less than twenty teams faced any legal issues regarding patenting and their parts [2]. This would likely be since the majority of teams worked in bacteria, where the parts have either never been patented, or any patents have since expired. However, as more explore synthetic biology in mammalian projects, patenting is going to become an unavoidable issue. Consequently, we propose two possible mechanisms for iGEM to handle patents on biological parts.
+
[6] Stricker, J, Cookson, S, Bennett, MR, Mather, WH, Tsimring, LS & Hasty, J 2008. "A fast, robust and tunable synthetic oscillator", <i>Nature</i>, vol. 456, pp. 516-520.
 +
[7] Lutz, R & Bujard H 1997. "Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and araC/I1-I2 regulatory elements", <i>Nucleic Acids Research</i>, vol. 25, no. 6, pp. 1203-1210.
-
[1] Lei, Z, Juneja, R & Wright, BD, 2009, ‘Patents versus patenting: implications of intellectual property protection for biological research’, Nature Biotechnology, vol. 27, pp. 36-40.
+
[8] Purcell, O, Savery, NJ, Grierson, CS & di Bernardo, M 2010. "A comparative analysis of synthetic genetic oscillators", <i>Journal of the Royal Society</i>, vol. 7, pp. 1503-1524.
-
[2] Mexico-UNAM-CINVESTAV, 2010, `Human Practices: Survey Results', accessed 4 August 2011 from https://2010.igem.org/Team:Mexico-UNAM-CINVESTAV/Home
+
[9] Kuhlman, TE & Cox, EC 2010. "Site-specific chromosomal integration of large synthetic constructs", <i>Nucleic Acids Research</i>, vol. 38, no. 6, pp. e92.

Latest revision as of 00:37, 6 October 2011




The human circadian rhythm drives many important processes in the body in accordance with the sleep/wake cycle. A characteristic of this biological clock is the periodic oscillation of gene expression. Current parts in the Registry designed to regulate periodic oscillations of gene expression have shown limited success.

Here we demonstrate the feasibility of a biological clock being standardised as a set of BioBrick parts.

Our network is controlled by an engineered promoter, Plac/ara, which features both an activator and a repressor domain. This controls the production of downstream genes to activate other inducible promoters, pBAD and GlnAp2, eventually leading to the production of a repressor protein, lacI, which inhibits Plac/ara, resulting in oscillatory expression. This project shows the feasibility of standardising the biological clock in E. coli and grounds further development for applications in regulated drug/hormone delivery and ion channel control.

UQ-Australia logo 2011.png


Project Details

The project has been split into categories:

  • Development of BioBricks
    • Experimental methods to be fully recorded in the Notebook
  • Modelling of the circuit
    • Modelling of the kinetics of the oscillating cells
    • Modelling of the synchronisation of oscillating cells
  • Thorough evaluation of the safety issues regarding UQ-Autralia's entry in iGEM
  • Human practices
    • Raising awareness of synthetic biology
    • Providing a solution to the patenting issue that iGEM is facing

Together, this forms the UQ-Australia project for the 2011 iGEM.


Motivation and Background

In humans, the circadian rhythm is controlled by several core genes that operate via a series of feedback loops (Figure 1). A transcription–translation negative-feedback loop powers the system, with a delay between the transcription of these genes and the negative feedback being a key factor that allows the system to oscillate [1]. A 'master clock' located in the Suprachiasmatic Nucleus coordinates the timing of the rhythm, but external factors such as light exposure play a large role in regulating the exact


Figure 1: The gene network responsible for establishing the circadian rhythm in humans [1]

Mammalian.png


There has been much effort put into reconstructing and determining the exact nature of this system, as the impact the circadian rhythm has on our lifestyle and cellular processes are still not very well understood. In particular, it is believed the circadian rhythm could exert an effect on everything from body temperature, feeding behaviour and appetite, hormone secretion and metabolism, glucose homeostasis, and cell-cycle progression [2].

Consequently, there have been a number of efforts to reconstruct this clock in a mammalian system for further study. In particular, both Hong et al. [3] and Tigges et al. [4] utilize the inducible tTa system to drive the expression and oscillation of genes in their synthetic networks.

It was our initial plan to construct a similar oscillatory system ourselves using standardized parts which could be added to the registry and then utilized by other iGEM teams working in mammalian cells. Such as system could be 'plugged in' to any number of different outputs and would allow for the timely and regular expression of the genes it drives. However, we encountered a number of issues around the intellectual property protecting of certain elements we wanted to use and so decided to switch to a simpler system in E. coli.

Our System

In prokaryotic systems, there are a number of tools available for synthetic biologists to construct gene networks such as the circadian clock we hope to replicate. In particular, we are going to make use of the inducible promoters glnAp2 and pBAD and their inducers glnG and araC. These components have been used in synthetic oscillators from both Atkinson et al. [5] and Stricker et al. [6]. In addition, we plan on using an engineered promoter denoted as Plac/ara, which features a pBAD activation domain as well as several lacO sites, meaning it is both inducible and repressible depending on the input. This promoter was first engineered by Lutz & Bujard [7].

Based on the work from these previous studies, we designed our own system using components that have been previously utilized to construct other synthetic clocks (Figure 2). We decided to make a 3 component system rather that a dual component system as the issues encountered by some other synthetic clocks suggest that there might not have been enough time between the transcription of various components [8]. As such, including this extra step to add a delay should ensure our network is able to reach an oscillatory expression pattern.

Figure 2: The genetic system we are aiming to construct in order to produce an oscillating gene network. An engineered promoter, Plac/ara, which features both an activator and a repressor domain controls the production of downstream genes to activate other inducible promoters, pBAD and GlnAp2. These eventually lead to the production of a repressor protein, lacI, which inhibits Plac/ara, resulting in oscillatory expression.

Oursystem.png


Once our system has been constructed, we hope to be able to make it even more stable by integrating the necessary components into the E coli chromosome. In this manner, we will be able to remove any interfering factors from our system, and will also be able to control the gene dosage level of our system. This has been a particular problem for other synthetic oscillators, with researchers being unable to control for the uptake of plasmid and therefore having cell-to-cell differences in the rate of oscillation [4, 6].

Kuhlman & Cox [9] have developed a method for integrating large synthetic constructs into the bacterial chromosome, and kindly provided us with the necessary plasmids should we reach this stage. Furthermore, Dr. Alex Ninfa [5] provided us with E. coli strain 3.300L*G, which has both glnG and lacI knocked out so as not to interfere with the network we construct.


Details on the modelling behind out circuit can be found on the Modelling page.

Experimental Outline & Goals

Our main aim for the experimental work is to produce each component as a standardized and characterised BioBrick part that can be re-used by other teams in future to build their own oscillators. In the long run, we would hope to produce an E. Coli strain incorporating the three main 'modules' of our oscillator. In this manner, other teams could use this strain and simply transform the bacteria with a plasmid driven by one of our inducible promoters in order to obtain regular, oscillating expression.

To achieve these goals, we must first source all the components we require and standardize them to include BioBrick sites. Standard BioBrick assembly can then be used to construct our main components, before we will utilize a pre-determined system and protocols [9] to attempt to integrate our modules into the chromosome. In the process of developing our parts and constructing the system, we hope to characterise all our parts. In particular, confirming the inducibility and kinetics of our promoters will allow us to refine our models.

Other activities

Our safety analysis is on the Safety page, while the Human Practices discussion is in the Human Practices section.


References

[1] Gallego, M & Virshup, DM 2007. "Post-translational modifications regulate the ticking of the circadian clock", Molecular Cell Biology, vol. 8, pp. 139-148.

[2] Takahashi, JS, Hong, HK, Ko, CH & McDearmon, EL 2008. "The genetics of mammalian circadian order and disorder: implications for physiology and disease", Genetics, vol. 9, pp. 764-775.

[3] Hong, HK, Chong, JL, Song, W, Song, EJ & Jyawook, AA et al. 2007. "Inducible and reversible Clock gene expression in brain using the tTa system for the study of circadian behaviour", PLoS Genetics, vol. 3, no. 2, 324-338.

[4] Tigges, M, Marques-Lago, TT, Stelling, J & Fusseneger, M 2009. "A tunable synthetic mammalian oscillator", Nature, vol. 457, pp. 309-312.

[5] Atkinson, MR, Savageau, MA, Myers, JT & Ninfa, AJ 2003. "Development of genetic circuitry exhibiting toggle switch or oscillatory behaviour in Escherichia coli", Cell, vol. 113, pp. 597-607.

[6] Stricker, J, Cookson, S, Bennett, MR, Mather, WH, Tsimring, LS & Hasty, J 2008. "A fast, robust and tunable synthetic oscillator", Nature, vol. 456, pp. 516-520.

[7] Lutz, R & Bujard H 1997. "Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and araC/I1-I2 regulatory elements", Nucleic Acids Research, vol. 25, no. 6, pp. 1203-1210.

[8] Purcell, O, Savery, NJ, Grierson, CS & di Bernardo, M 2010. "A comparative analysis of synthetic genetic oscillators", Journal of the Royal Society, vol. 7, pp. 1503-1524.

[9] Kuhlman, TE & Cox, EC 2010. "Site-specific chromosomal integration of large synthetic constructs", Nucleic Acids Research, vol. 38, no. 6, pp. e92.

Retrieved from "http://2011.igem.org/Team:UQ-Australia/Project"